Stephen Jensik to Humans
This is a "connection" page, showing publications Stephen Jensik has written about Humans.
Connection Strength
0.031
-
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
Score: 0.017
-
Arteriovenous fistula patency in the 3?years following vonapanitase and placebo treatment. J Vasc Surg. 2017 Apr; 65(4):1113-1120.
Score: 0.014